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ABSTRACT 
 
Objectives: This study aimed to examine the differential contribution of demographic and medical 
characteristics on severity of gastrointestinal symptoms in a sample of patients with IBS or IBD 
recruited from outpatients with gastrointestinal disorders. In addition this study aimed to explore the 
role of alexithymia and defense style on gastrointestinal symptoms. 
Methods: The participants consisted of 65 outpatients with an IBS or IBD diagnosis who completed a 
demographic questionnaire, the Toronto Alexithymia Scale – 20 (TAS-20), the Defense Style 
Questionnaire (DSQ), and the Gastrointestinal Symptom Rating Scale (GSR).  
Results: ANOVA showed no significant effect of specific diagnosis on the severity of gastrointestinal 
symptoms. Results of MANCOVA showed that there was a significant multivariate effect of gender 
with female scoring significantly higher than males on severity of intestinal symptoms. Other variables 
such as age, level of education, years since diagnosis did not reach a significance on the dependent 
variables. In addition the defense style defined “maladaptive” had a significant effect on dyspeptic 
symptoms. 
Conclusions: Our results have shown the influence of the maladaptive defense style on the severity of 
symptoms with no differences for the two considered diagnosis. Moreover they are coherent with past 
studies highlighting the risk for the female gender to develop a somatic disease 
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Introduction 
 
The Irritable Bowel Syndrome (IBS) is classified as functional gastrointestinal disorders 
(Schmulson & Drossman, 2017).  Symptoms of functional gastrointestinal disorders are associated 
with a strong impairment in daily functioning and a worse health-related quality of life, work 
absenteeism, and high medical costs (Gralnek, Hays, Kilbourne, Naliboff, & Mayer, 2000; 
Portincasa, Moschetta, Baldassarre, Altomare, & Palasciano, 2003). Individuals with IBS have 
higher levels of anxiety and depression compared with controls (Sibelli et al., 2016). The quality of 
life of IBS patients is significantly lower than the general population and it is correlated with 
perceived stress (Edman et al., 2017). Psychological disorders often head or worsen symptoms and 
correlate with symptom severity and health outcomes (Wouters & Boeckxstaens, 2016).  
Alexithymia is considered a reliable and stable predictor of treatment in patient with functional 
gastrointestinal disorders (Porcelli et al., 2003).  Alexithymia was found to be a stronger predictor 
of treatment outcome than gastrointestinal-specific anxiety in IBS (Porcelli, De Carne, & Leandro, 
2017). Hence, treatment outcome could be more efficacy by identifying patients with high 
alexithymia. 
Nevertheless, there are more evidences for the use of psychological interventions in IBS than in 
Inflammatory Bowel Disease (IBD) and further research is still necessary (Ballou & Keefer, 2017).  
Anxiety and depression were common in IBD patients and were correlated with an impairment 
quality of life (Chan et al., 2017). On the other hand, agreement between gastroenterologists and 
IBD patients regarding the presence of clinically significant anxiety or depression was low 
(Janmohamed & Steinhart, 2017). Among patients with IBD, anxiety and depression can exacerbate 
symptoms of the disease mostly during active phase (Graff, Walker, & Bernstein, 2009). Moreover, 
there is a relationship between anxious and avoidant attachment styles and severity of the symptoms 
in IBD patients (Agostini et al., 2010; Gick & Sirois, 2010). Several research have attempt to 
explore alexithymia in IBD patients. In fact alexithymia has an independent influence on the 
subjective health status of patients with IBD (Verissimo, Mota-Cardoso, & Taylor, 1998). An 
highly prevalence of alexithymia was found in patients with IBD (Iglesias-Rey et al., 2012). 
Alexithymia is a stable personality variable differently from anxiety and depression that are 
influenced by the level of disease activity (Porcelli, Leoci, Guerra, Taylor, & Bagby, 1996). 
Regarding gender, it seems that females with high alexithymic level are more inclined to developed 
IBD and other psychosomatic diseases (La Barbera et al., 2017). 
In addition, defense mechanisms ad reaction-formation and somatization seem to be independent 
correlates quality of life in IBD patients (Hyphantis et al., 2009). Hence, these aspects of 
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personality are likely to influence the patients’ adaption to the IBD. More specifically Crohn’s 
disease patients showed a more immature defensive profile than Ulcerative colitis patients using 
style as maladaptive action (Hyphantis et al., 2005). However, few studies have evaluated defense 
mechanisms and other personality variables in IBD patients comparing with IBS. 
Personality traits and emotional control such as alexithymia should be addressed by clinicians to 
improve adjustment in IBD patients (Jordan, Sin, Fear, & Chalder, 2016). 
The first aim of this study was to explore the role of demographic and medical variables on the 
gastrointestinal symptoms in IBS and IBS patients. The second aim of this study was to examine the 
role of alexithymia and defense style on gastrointestinal symptoms. 
 
Methods 
Participants 
A convenience sample of 65 outpatients from the Clinical Unit for Chronic Bowel Disorders of the 
Department of Clinical and Experimental Medicine, University Hospital of Messina participated in 
this study.  
All patients were native Italian speakers and Italian nationals. Inclusion criteria were a diagnosis of 
IBD or IBS, be older than 18 years, able to understand Italian language and answer to questionnaire. 
Exclusion criteria included pre-existing psychopathology or neurological disorders that could 
interfere with the completion of the instruments.  
 
Procedure 
Ethical approval was obtained from the Ethics Committee of the hospital. Patients were enrolled 
over a 6-month period in the Clinical Unit for Chronic Bowel Disorders of the hospital. Patients 
were recruited on a voluntary basis and were informed about the aim of the study before to sign an 
informed consent sheet. The consent form informed participants of their right to withdraw the study. 
All the procedures of this study were in accordance with the ethical standards of the Helsinki 
Declaration. All patients were recruited after an assessment by a gastroenterologist for verify an 
IBD or IBS diagnosis. Psychological assessment were conducted according to standardized 
procedures. Medical information was obtained by the gastroenterologists of the unit. 
 
Measures 
Demographic information included age, gender, educational degree, nationality, marital status. 
Medical information included diagnosis, data on the disease and the history of treatment. 
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The Twenty-Item Toronto Alexithymia Scale (TAS-20; Bagby, Parker, & Taylor, 1994). This a 20 
item self-report scale that measures the alexithymia construct. The items are rated on a 5-point 
Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). The TAS-20 scores for three 
factors named: difficulty identifying feelings (DIF), difficulty describing feelings (DDF), and 
externally oriented-thinking (EOT). Moreover, a total score of the TAS-20 is calculated by the sum 
of the subscales. In this study, a validated Italian version (Bressi et al., 1996) of the TAS-20 was 
used that has good psychometric properties as the original version. Reliability of all three factors 
and the total score was good, with Cronbach’s α of .85 for DIF, .75 for DDF, .75 for EOT, and .85 
for the total score. 
Defense Style  Questionnaire-88 (DSQ-88; Bond, 1986). This is a 88 item self-report scale that 
assess ego defense mechanisms through their conscious derivates in everyday life. This version of 
the DSQ consists of 88 items evaluated on a 9-point Likert ranging from 1 (strongly disagree) to 9 
(strongly agree) that reflect 25 defense mechanisms and four defense styles. The four defense styles 
are named, respectively, “maladaptive” (Style 1), “image-distorting” (Style 2), “self-sacrifice” 
(Style 3), and “adaptive styles” (Style 4). A “Lie Scale” is included through items that represent 
social desirability. In this study, a validated Italian version of the MCQ-30 was used to assess 
defense styles (San Martini, Roma, Sarti, Lingiardi, & Bond, 2004). The Italian version of the DSQ-
88 showed a hierarchical model of defensive functioning compatible with the original 
questionnaire. A sufficient internal consistencies was found for the defense styles, with the 
exception of the Adaptive Style scale. Reliability of all four defense styles in the present sample 
was sufficient to good for the Maladaptive Style (α = .90), the Image-distorting Style (α = .75), and 
Self-sacrificing Style (α = .69) but not for the Adaptive Style (α = .49).  
Gastrointestinal Symptom Rating Scale (GSRS; Svedlund, Dotevall, & Sjodin, 1998). This is an 
observer-rated illness specific questionnaire. The scale includes 15 symptoms rated on a 4-point 
Likert scale ranging from 0 (which denotes no symptoms) to 3 (which denotes the most pronounced 
symptoms) divided in three subscales and a total score. The three subscales correspond to dyspeptic 
(DYS), digestive (DIG), and intestinal (INT) syndromes. The total score represents overall 
frequency and severity of gastrointestinal symptoms.  
In this study, a validated Italian version of the GSRS was used to assess gastrointestinal symptoms 
(Kulich et al., 2004). The GSRS is a well-validated and used widely measure in gastrointestinal 
research (Wiklund, 1993) and the Italian version has good psychometric properties. 
Reliability of the three scales and the total score was sufficient to good, with Cronbach’s α of .66 
for SD, .69 for SCD, .67 for SDI, and .79 for the total score. 
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Statistical analyses 
Analyses were performed with SPSS v.22 (SPSS Inc. 2013) statistical software and Excel software. 
Data obtained from the research was checked and subsequently analyzed by descriptive and 
inferential statistical analysis. Descriptive statistics such as the means and standard deviations of the 
variables are reported. The data shows a good range of variance and there were no unvaried outliers 
for all the variables considered. 
Statistical analysis was carried out with the use of means and SDs, multivariate analysis of variance 
(MANOVA), and test post-doc. Subsequently, an identical MANCOVA was performed, controlling 
for participant age, gender, level of education and medical variables. Another MANCOVA was 
performed, controlling the three factors of the TAS-20 and the three defense styles of the DSQ-88. 
The levels of statistical significance were set at p ≤ .05 and p ≤ . 01. 
 
Results 
Demographic and medical characteristics 
The convenience sample consisted of 22 patients with UC, 20 patients with IBS, and 19 patients 
with CD. Demographic and medical characteristics of the sample are presented in Table 1. 
The sample of patients with UC consisted of 10 males and 12 females, the mean age was 37.32 
years (SD = 12.71; range = 21-62), the level of education in years was 11.05 (SD = 3.48; range = 5-
18). Fifty-nine percent were married and seventy-three percent were employed. 
With respect to medical status, the mean of years since symptoms began was 7.42 years (SD = 8.61; 
range = 0.25- 30) and the mean of treatment was 5.04 years (SD = 6.03; range = 0.08-22). 
The sample of patients with IBS consisted of 9 males and 11 females, the mean age was 39.30 years 
(SD = 19.80; range = 17-76), the level of education in years was 11.05 (SD = 4.54; range = 5-18). 
Fifty percent were married and sixty percent were married. 
With respect to medical status, the mean of years since symptoms began was 6.22 (SD = 10.53; 
range = 0.08-30) and the mean of treatment was 2.93 years (SD = 6.82; range = range = 0.08-30). 
The sample of patients with CD consisted of 12 males and 7 females, the mean age was 39.84 years 
(SD = 14.46; range = 21-68), the level of education in years was 14.32 (SD = 3.67; range = 8-18). 
Fifty-three percent were married and seventy-four were employed. 
With respect to medical status, the mean of years since symptoms began was 8.72 (SD = 5.54; 
range = 2-17) and the mean of treatment was 4.68 years (SD = 4.74; range = 0.08-15) 
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 Groups 
Variables UC (n = 22) IBS (n = 20) CD (n = 19) 
Age (years) - M(SD) 37.32(12.71) 39.30(19.80) 39.84(14.46) 
Level of education (years) - M(SD) 11.05 (3.48) 11.05 (4.54) 14.32 (3.67) 
Male (%) 45 45 63 
Female (%) 55 55 37 
Single (or separated/widowed) (%) 41 50 47 
Married (%) 59 50 53 
Employed (%) 73 60 74 
Unemployed (%) 27 40 26 
Years since diagnosis - M(SD) 7.42(8.61) 6.22(10.53) 8.72(5.54) 
Years undergoing treatment - M(SD) 5.04(6.03) 2.93(6.82) 4.68(4.74) 
Notes: UC: ulcerative colitis; IBS: irritable bowel syndrome; CD = Chron’s disease. 
Table 1. Demographic and medical characteristics of the sample 
 
Analysis of multivariate effects of diagnosis sample on gastrointestinal symptoms 
A MANOVA was carried out with the three subscales and the total score of GSRS as the dependent 
variables and diagnosis sample (UC, IBS, and CD) as independent variables. Results did not show a 
significant multivariate effect of diagnosis [Wilks’ Lambda = .884, F(6, 112) = 1.182, p = .32, np2 = 
.060] on the dependent variables.  
 
  UC (n = 22) IBS (n = 20) CD (n = 19)   
Variable α M SD M SD M SD F p 
DYS .66 4.05 2.59 4.40 1.93 4.37 2.41 .149 .86 
DIG .69 4.55 2.30 4.20 2.71 4.73 2.33 .254 .78 
INT .67 3.32 2.78 5.40 3.07 5.21 3.51 2.887 .06 
Total score GSRS .79 11.91 5.85 14.32 6.99 14.00 5.74 .936 .40 
Notes: DYS: dyspeptic symptoms; DIG: digestive symptoms; INT: intestinal symptoms; GSRS: 
Gastrointestinal Symptom Rating Scale. 
 
Table 2. Descriptive statistics and analysis of the effect of patient sample on gastrointestinal symptoms 
 
Analysis of multivariate effects of diagnosis sample on gastrointestinal symptoms adjusting for 
age, gender, level of education, years since diagnosis, and years undergoing treatment 
An identical MANCOVA, with age, gender, level of education, years since diagnosis, and years 
undergoing treatment as covariates was carried out. After adjustment for these variables, there was a 
significant multivariate effect of gender [Wilks’ Lambda = .860, F(3, 51) = 2.769, p < .05, np2 = .140] 
with females scoring significantly higher than males on severity of intestinal symptoms, F(7, 15) = 
7.050,  p < .01, np2 = .117. The other variables did not reach significance on the dependent 
variables. 
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Analysis of multivariate effects of diagnosis sample on gastrointestinal symptoms adjusting for 
alexithymia factors and defense styles 
A MANCOVA was carried out with the three subscales of GSRS as the dependent variables and 
diagnosis sample (UC, IBS, and CD) as independent variables, adjusting for the three factors of the 
TAS-20 and the three defense styles of the DSQ-88. There was a significant multivariate effect of 
the Style 1, named “maladaptive”, on the dependent variables [Wilks’ Lambda = .844, F(3, 49) = 
3.017, p < .05, np2 = .156]. In fact, the Style 1 had a significant effect on dyspeptic symptoms, F(9, 51) 
= 5.359,  p < .01, np2 = .095.  
Discussion 
In the present study, we examined the role of demographic and medical characteristics on IBS and 
IBD patients. Moreover we investigated the influence of alexithymia and defense styles on the 
severity of gastrointestinal symptoms. Past studies have separately considered these diagnoses even 
though psychological variables play a key role in both conditions. At this regard three diagnosis 
(Chron’s disease, Ulcerative colitis, and Irritable bowel syndrome) were included and results did 
not show any significant difference for severity of symptoms. 
The subsequent step was to include demographic and medical characteristics such as age, gender, 
level of education, years since diagnosis, and years undergoing treatment. The only variable that 
showed a significant multivariate effect was the gender. In fact, females displayed higher severity of 
symptoms than males. This result is coherent with past studies highlighting the risk for the female 
gender to develop a somatic disease. Hence, clinicians should address not only medical variables 
but also demographic characteristics such as gender.  
Past studies have also shown the role of personality traits on the quality of life of patients. At this 
regard many research pointed out the role of variables such as neuroticism, emotional control, and 
alexithymia. Results of this study have shown the influence of the maladaptive defense style on the 
severity of symptoms with no differences for the three considered diagnosis. In this perspective, a 
multidisciplinary approach to these diseases is fundamental to a better compliance and efficacy of 
the patients. The assessment of psychological functioning and the subsequent psychological 
intervention could help the patient with IBS or IBD to obtain a higher quality of life. 
The results of this study highlighted the role of demographic variables taken together to some 
personality traits for a better efficacy of treatment.  
This study has two major limitations. The first was the absence of a control sample from the normal 
population even though our aim was to compare organic and functional diseases. The second limit 
was the small size of the sample. Future research should extend the sample to verify the finding in a 
larger sample. 
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